Dr. Albert Bourla became Pfizer CEO in January 2019. He began his career at the company in 1993, in the Animal Health Division as Technical Director of Greece, and has served in numerous executive positions within the company, including Chief Operating Officer, Group President of Pfizer Innovative Health, and Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business. He is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In addition to his responsibilities at Pfizer, Dr. Bourla is on the executive committee of The Partnership for New York City, a director on multiple boards, including Pfizer, Inc., PhRMA, and Catalyst, a Trustee of the United States Council for International Business, and a member of the Business Roundtable and the Business Council. In 2020, Dr. Bourla was named America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine.
